Homology modeling and molecular docking studies of DNA replication licensing factor minichromosome maintenance protein 5 (MCM5)

 

Manish Devgan*

Faculty of Pharmacy, R.P. Educational Trust Group of Institutions, Bastara, Karnal-132001, Haryana, India.

*Corresponding Author E-mail: manishdevgan12@gmail.com

 

ABSTRACT:

Minichromosome maintenance proteins (MCM2-7) form the important part of the DNA replication initiation system. The MCM proteins contribute to restricting the initiation of DNA replication to once per cycle. A heteromeric complex is formed by binding of these six proteins with each other. The aim of this work was to prepare the homologous model of MCM5 protein and perform the docking studies. In this work, a theoretical model of MCM5 protein was generated using the concepts of homology modeling and loop modeling. The resulting model was validated by Procheck with Ramachandran plot analysis. The ligands generated with the help of Drug bank and ZINC data base were docked against MCM5 protein using DockThor portal. The study revealed that the compound acetonyl-cycloheptyl-cyclohexyl-BLAHtrione (ZINC15861168) has the maximum probability to bind with MCM5. Thus, the usage of this compound can lead to inhibition of the protein MCM5 which will act as a blockade in the formation of heteromeric complex of MCM2-7 proteins thereby assisting in the treatment of multiple myeloma and other cancer cells.

 

KEY WORDS: Minichromosome maintenance proteins, molecular modeling, homology modeling, loop modeling, molecular docking.

 

 


INTRODUCTION:

Minichromosome maintenance proteins (MCM2-7) belong to a family of evolutionarily highly sustained protein. These six proteins form the important part of the DNA replication initiation system1,2. The MCM proteins contribute to restricting the initiation of DNA replication to once per cycle3,4. A heteromeric complex is formed by binding of these six proteins with each other5. One study showed that in addition to the role in DNA replication, the MCM proteins are also crucial for transcription activation6.

 

In humans, the MCM gene encodes the protein called as DNA replication factor MCM5. This protein is structurally homologous to CDC46 protein from Saccharomyces cerevisiae7. Many studies have demonstrated that MCM proteins may be better indicators of a wide variety of proliferative or cancer cells in malignant tissues8-14. In one study it was seen that Aplidin displayed anti-multiple myeloma activity in a mouse xenograft model, which may be due to restraining of a collection of proliferative/ antiapoptic genes (e.g., MCM2, MCM4, MCM5) and up regulation of several possible regulators of apoptosis15.

 

Another study demonstrated that Prohibitin, a tumour suppression protein, interacts with MCM proteins and can act as an effective inhibitor of DNA replication16.

 

The most common problem in biology is the functional characterization of a protein sequence. There are some proteins which are too big for NMR analysis and also their structure cannot be predicted by X-ray diffraction. This work is normally made easy by precise three dimensional (3-D) structure of the studied protein. When experimental techniques fail then protein modeling is the only way to extract the structural information. Homology modeling estimates the 3-D structure of a given protein sequence (target) based principally on its alignment to one or more proteins of known structures (templates). The estimation process consists of fold assignments, model building and model evaluation17,18. One study suggested that the combination of structure-based docking and advanced protein structure modeling should be an important approach to the large-scale drug screening and discovery studies19. The homology modeling has been widely used to predict the protein structure20,21. In this study, we designed the structure of MCM5 protein, by using homology modeling. Finally the docking of the ligands was done to predict the binding orientation of small drug molecules with their protein target (MCM5) in order to predict the affinity and activity of the small molecules in inhibiting MCM5 so that the MCM heteromeric complex is blocked, which in turn will lead to inhibition of DNA replication.

 

Materials And Methods:

The hardware used for calculating molecular modeling includes a personal computer with Intel (R) Core (TM) i3 CPU processor, Windows 7 Home Premium 32-bit operating system having RAM of 2.00 GB.

 

Sequence Alignment

Fast Alignment (FASTA)

The FASTA format is a text based format for representing either nucleotide sequences or peptide sequences, in which nucleotides or amino acids are represented using single letter codes22. The FASTA sequence of MCM5 was acquired from the website of National Centre for Biotechnology Information23.

 

Basic Local Alignment Search Tool (BLAST)

The BLAST is an algorithm for comparing primary biological sequence information, such as the amino acid sequence of different proteins or the nucleotides of DNA sequences24. Using the FASTA sequence, the standard protein BLAST was performed on the NCBI. The protein data bank proteins data base was chosen and the BLAST-P was performed.

 

Three Dimensional Position-Specific Scoring Matrix (3D-PSSM)

The 3D-PSSM is a fast web based method for protein fold recognition using 1D and 3D sequence profiles coupled with secondary structure and salvation potential information25. The FASTA sequence was submitted to 3D-PSSM for fold recognition.

 

Protein Homology/Analogy Recognition Engine (Phyre)

Phyre is a web based service for protein structure prediction. Phyre is among the most popular methods for protein structure prediction26. The FASTA sequence was submitted to Phyre for amino acid sequence prediction27. 

 

Templates Preparation

The data obtained from combined 3D-PSSM and Phyre was subjected to RCSB protein data bank28. The templates were selected on the basis of their resolution (Å) and R-value. All the above templates were submitted by X-ray crystallography method in PDB29.

 

Molecular Modeling

Homology modeling of MCM5 was done by using EasyModeller30. Easy Modeller is a graphical user interface to Modeller program. It is a standalone tool in windows platform with Modeller and Python preinstalled31. The Swiss-Pdb viewer was installed from the respective site which is an application that provides a user friendly interface allowing analyzing several proteins at the same time32.

 

 

Structure Prediction

The six templates were submitted to the EasyModeller and were aligned. The Discreet Optimized Protein Energy (DOPE) score is a statistical tool to assess homology models in protein structure prediction. The model with the minimum score can be chosen as the best possible structure.

 

Validation of Predicted Model

The validation of all the five models was performed by using Procheck in SAVS, i.e., Structural Analysis and Verification Server33. The Ramachandran plot validated the result. The residues in the most favoured region are at maximum and those in the generously allowed and disallowed regions are at minimum.

 

Loop Modeling

The loop region in the given protein very often contribute to binding sites and determine the functional specificity of a given protein framework. The co-ordinate file in PDB format was submitted for loop optimization to ModLoop, i.e., Modeling of Loops in Protein Structures. ModLoop is a web server for automated modeling of loops in protein structures. It has been developed by Andras Fiser34,35. The resulting co-ordinate file was sent back by e-mail. This structure was validated by using SAVS. The process of loop modeling and subsequent validation was continued till an optimized structured model of protein was obtained.

 

Ligand Generation

The literature survey revealed the inhibitory action of Aplidin against MCM protein15. The Aplidin (DB04977) was used to search for the similar drugs in the Drug Bank and ZINC databases36,37.

 

Molecular Docking

The molecular docking is an important tool in structural molecular biology and computer-assisted drug designing38. The docking of these drugs was performed by using free online server DockThor Portal. The implemented DockThor program is a flexible-ligand and rigid-receptor grid based method that employs a multiple solution genetic algorithm and the MMFF94S molecular force field scoring function39. Both the macromolecule and ligands were prepared for docking with the help of PyMol and chemBio3D computer software respectively40,41. The molecular docking of these drugs was done against MCM5 protein model using online docking server DockThor. The default settings of grid dimensions were employed. The default value of spatial discretization of the energy grid (0.25Å) was used and the grid points were fixed at 704969.

 

Grid Centre:          Grid Dimensions (±ΔX; ±ΔY; ±ΔZ):

Xc = 16                                                                  X = 11

Yc = 6                                                                    Y = 11

Zc = 20                                                                  Z = 11

 

The best compound was selected on the basis of the total energy (intermolecular ligand-receptor + intramolecular ligand energies) or Interaction energy (only intermolecular ligand-receptor energy) and the root mean square deviation.

Results And Discussion

Template Generation

FASTA sequence of MCM5 was retrieved from the website of NCBI. The NCBI reference sequence is CAG30403.1. The BLAST was performed on the NCBI and 18 hits were recorded (Figure 1). The FASTA sequence was subjected to 3D-PSSM and Phyre for prediction of protein structure. The results obtained were combined and ranked in the descending order of % ID. The subjection of this data to RCSB protein data bank led to the selection of six templates (PDB ID: 3F8T, 2ENX, 1VMH, 1OFH, 2C90, 3K1J) with their resolution < or = 3.00 Å and the R- value is < or = 0.5 (Table 1).

 

Table 1. Generation of templates using 3D-PSSM, Phyre and RCSB protein data bank.

S.

No.

Name

ID %

Resolu-tion

R-Value

PDBID

1

3F9VA

37

4.35

0.415

3F9V

2

4FDGB

37

4.10

0.332

4FDG

3

3ZEND

30

7.5

-

3ZEN

4

3F8TA

29

1.9

0.214

3F8T

5

2ENXA

29

2.8

0.196

2ENX

6

1VMHA

29

1.31

0.159

1VMH

7

1OFHA

28

2.5

0.224

1OFH

8

c2c90A

28

2.2

0.209

2C9O

9

C3K1jA

27

2.0

0.206

3K1J

10

2X47A

26

1.7

0.167

2X47

11

3PVCA

26

2.31

0.173

3PVC

 

Homology Modeling

The five models were generated with the help of EasyModeller and their DOPE score was obtained (Table 2). The model number 1 scored the minimum and was selected.

 

Validation:

The models were further validated by Procheck in SAVS. The Ramachandran plot validated and supported the earlier decision of selecting the model number 1, as the sum of residues in most favoured region (71.8%) and residues in additional allowed regions (21.7%) comes out to be highest, and the sum of residues in generously allowed region (4.1%) and residues in disallowed regions (2.3%) comes out to be lowest among all the models (Table 2).

 

Loop modeling

The PDB file format of model number 1 was submitted for loop optimization to ModLoop and the structure was validated by using SAVS. The model was validated as it had maximum percentage of residues in most favoured region (93.7%) and no residue in generously allowed as well as disallowed regions (Figure 2).

 

The model of MCM5 protein (Figure 3) was successfully submitted to Protein model data base bearing the PMDB ID: PM007964942.


 

Figure 1. Distribution of 18 BLAST hits on the query sequence (query Id:  Gi|47678565|emb|CAG30403.1) in pdb protein database.

 

Table 2. DOPE score and Ramachandran plot statistics of the five possible models of AMF.

S.

No.

Query

File

Name

Molpdf

DOPE score

GA341

score

Residues in most favoured region (%)

Residues in additional allowed region (%)

Residues in generously allowed regions (%)

Residues in disallowed regions (%)

1

B99990001.pdb

38392.33203

-47071.94922

0.01582

71.8

21.7

4.1

2.3

2

B99990002.pdb

39515.19141

-44707.50781

0.01502

71.2

18.7

5.4

4.7

3

B99990003.pdb

39084.29297

-46161.54688

0.00532

71.7

20.5

5.2

2.6

4

B99990004.pdb

38443.04297

-43528.59375

0.00862

73.4

19.4

4.3

2.9

5

B99990005.pdb

39131.90625

-44203.32813

0.00788

71.8

20.8

4.4

2.9

 

 

Table 3. Docking result of ligands against MCM5 as target.

S.

No.

Accession No.

Total Energy (T.E) (Kcal/

mol)

Interaction Energy (I.E) (Kcal/mol)

Root Mean Square Deviation (RMSD) (Å)

S. No.

Accession No.

Total Energy (T.E) (Kcal/mol)

Interaction Energy (I.E) (Kcal/

mol)

Root Mean Square Deviation (RMSD) (Å)

1

ZINC15861168

12.855

-0.001

0.000

36

ZINC35340021

41.846

-0.001

0.000

2

ZINC15861121

17.733

-0.001

0.000

37

ZINC37538182

42.792

-0.001

0.000

3

ZINC15861137

18.545

-0.002

0.000

38

ZINC35340007

44.128

-0.002

0.000

4

ZINC15861138

21.200

-0.001

0.000

39

ZINC35340016

44.179

-0.002

0.000

5

ZINC35339905

21.562

-0.001

0.000

40

ZINC35339971

53.633

-0.001

0.000

6

ZINC15861184

21.66

-0.001

0.000

41

DB04191

71.356

-0.002

0.000

7

ZINC15861122

22.966

-0.001

0.000

42

ZINC79221126

75.183

-0.001

0.000

8

ZINC35339900

23.208

-0.001

0.000

43

ZINC79221118

75.386

-0.000

0.000

9

ZINC35339889

23.392

-0.001

0.000

44

ZINC79221195

76.731

-0.002

0.000

10

ZINC35339896

23.933

-0.001

0.000

45

ZINC79221186

76.940

-0.001

0.000

11

ZINC15861185

25.716

-0.001

0.000

46

ZINC67910488

77.062

-0.001

0.000

12

ZINC04665026

25.725

-0.001

0.000

47

ZINC79216746

77.231

-0.001

0.000

13

ZINC35339965

25.828

-0.001

0.000

48

ZINC79216743

77.639

-0.002

0.000

14

ZINC43766843

27.165

-0.001

0.000

49

ZINC79221183

78.273

-0.001

0.000

15

ZINC35339927

28.201

-0.001

0.000

50

ZINC79221177

78.602

-0.001

0.000

16

ZINC35339886

28.282

-0.002

0.000

51

ZINC67910490

82.136

-0.002

0.000

17

ZINC35339892

28.464

-0.002

0.000

52

ZINC67910485

82.671

-0.001

0.000

18

ZINC35339923

29.917

-0.001

0.000

53

ZINC67910538

86.164

-0.001

0.000

19

ZINC35339834

32.181

-0.001

0.000

54

ZINC67910540

86.849

-0.001

0.000

20

ZINC35339829

34.474

-0.001

0.000

55

ZINC67910544

88.506

-0.002

0.000

21

ZINC35339878

34.731

-0.001

0.000

56

ZINC67911060

89.913

-0.003

0.000

22

ZINC35339883

35.397

-0.001

0.000

57

DB05426

90.162

-0.001

0.000

23

ZINC35340003

35.616

-0.001

0.000

58

ZINC67911062

90.189

-0.003

0.000

24

ZINC67297448

35.936

-0.001

0.000

59

ZINC67910545

91.973

-0.001

0.000

25

ZINC35339969

37.072

-0.001

0.000

60

ZINC67911064

93.237

-0.002

0.000

26

DB07219

37.121

-0.001

0.000

61

ZINC67911067

94.252

-0.002

0.000

27

ZINC37538176

37.414

-0.001

0.000

62

DB08889

126.009

-0.000

0.000

28

ZINC35339909

37.814

-0.001

0.000

63

DB03393

131.549

-0.003

0.000

29

ZINC35339999

38.138

-0.001

0.000

64

DB04977

134.034

-0.002

0.000

30

ZINC35339912

38.277

-0.001

0.000

65

DB06663

138.647

-0.001

0.000

31

ZINC67297434

38.509

-0.002

0.000

66

DB08890

150.493

-0.004

0.000

32

ZINC37538178

38.994

-0.001

0.000

67

DB01723

157.154

-0.168

0.000

33

ZINC35339967

39.674

-0.001

0.000

68

DB05128

159.637

-0.003

0.000

34

ZINC37538180

40.857

-0.001

0.000

69

DB01369

187.235

-0.002

0.000

35

ZINC01380951

41.81

-0.001

0.000

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ligand Generation

From the Drugbank and ZINC databases sixty nine (69) compounds similar to Aplidin were selected.

 

Molecular Docking

The molecular docking of these 69 compounds was done against the model of MCM5 protein using the online server DockThor (Table 3). The results suggested that the docking of the compound ZINC15861168 (acetonyl-cycloheptyl-cyclohexyl-BLAHtrione) with MCM5 protein was held with least total energy of 12.855 Kcal/mol and interaction energy of -0.001 Kcal/mol when compared with the compound Aplidin (total energy: 134.034 Kcal/mol; interaction energy: -0.002 Kcal/mol).


 

Figure 2. Ramachandran plot for optimized model of MCM5 protein.

 


 

Figure 3. Optimized model of MCM 5 protein.

 

Conclusion:

The model of MCM5 protein was created by using the concepts of homology and loop modeling. The model was validated by the Ramachandran plot. Various ligands were identified using Drug bank and ZINC database. The molecular docking done against MCM5, of these ligands using online docking server Dockthor identified compound ZINC15861168 (acetonyl-cycloheptyl-cyclohexyl-BLAHtrione) with least total energy of 12.855 Kcal/mol. The study suggested that the above said compound bears the minimum binding energy with MCM5 protein and thus has the maximum probability to bind with it. Thus, the usage of this compound can lead to inhibition of the protein MCM5 which will act as a barricade in the formation of heteromeric complex of MCM2-7 proteins thereby assisting in the treatment of multiple myeloma and other cancer cells.

 

References:

1      Dudderidge TJ et al.  Diagnosis of prostate cancer by detection of minichromosome maintenance 5 protein in urine sediments. British Journal of Cancer. 103 (5); 2010: 701-707.

2      Synder M, Huang XY and  Zhang JJ. The minichromosome maintenance proteins 2-7 (MCM2-7) are necessary for RNA polymerase II (Pol II)-mediated transcription. Journal of Biological Chemistry. 284 (20); 2009: 13466-13472. 

3      Gauthier L et al. The role of the carboxyterminal domain of RNA polymerase II in regulating origins of DNA replication in Saccharomyces cerevisiae. Genetics. 162 (3); 2002: 1117-1129.

4      Hill AL, Phelan SA and Loeken MR. Reduced expression of pax-3 is associated with over expression of cdc46 in the mouse embryo. Development Genes and Evolution. 208 (3); 1998: 128-134.

5      Miyake S and Yamashita S. Identification of sna41 gene, which is the suppressor of nda4 mutation and is involved in DNA replication in Schizosaccharomyces pombe. Genes to Cells: devoted to cellular and molecular mechanisms. 3 (3); 1998: 157-166.

6      Synder M, He W and Zhang JJ. The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America. 102 (41); 2005: 14539-14544.

7      Wikipedia. MCM5. Wikipedia [cited 2014 Nov 8]. Available from: http://www.en.wikipedia.org/wiki/MCM5 

8      Stoeber K et al. Diagnosis of genito-urinary tract cancer by detection of Minichromosome Maintenance 5 protein in urine sediments. Journal of the National Cancer Institute. 94 (14); 2002: 1071-1079.

9      Yu SY et al. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 43 (5); 2014: 344-349.

10    Liu H et al. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases. International Journal of Dermatology. 46 (11); 2007: 1171-1176. 

11    Going JJ et al. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett’s mucosa. Gut. 50 (3); 2002: 373-377.

12    Giaginis C et al. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. Digestive Diseases and Sciences. 56 (3); 2011: 777-785.

13    Saydam O et al. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. Journal of Proteome Research. 9 (1); 2010: 485-494.

14    Ayaru L et al. Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates. British Journal of Cancer. 98 (9); 2008: 1548-1554.

15    Mitsiades CS et al. Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo. Cancer Research. 68 (13); 2008: 5216-5225.

16    Rizwani W, Alexandrow M and Chellappan S. Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication. Cell Cycle. 8 (10); 2009: 1621-1629.

17    Krieger E, Nabuurs SB and Vriend G. Homology Modeling. In Structural Bioinformatics, Edited by Bourne PE and Weissig H. John Wiley & Sons, Inc, Hoboken, NJ, USA. 2005; Vol 44: pp. 507-521.

18    Webb B and Sali A. Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics. 47; 2014: 5.6.1-5.6.32.

19    Du H et al. Protein structure prediction provides comparable performance to crystallographic structures in docking-based virtual screening. Methods. 71 (1); 2015: 77-84.

20    Sivakamavalli J et al. Homology modelling, molecular dynamics, and docking studies of pattern-recognition transmembrane protein-lipopolysacccharide and β-1,3 glucan-binding protein from Fenneropenaeus indicus. Journal of Biomolecular structure and Dynamics. 20; 2014: 1-12.

21    Khan N et al. Insilico approach to predict the structure of amyloid precursor protein responsible for Alzheimer disease. Journal of Advanced Bioinformatics Applications and Research. 3 (2); 2012: 333-338.

22    Wikipedia. FASTA. Wikipedia [cited 2014 May 06]. Available from: http://www.en.wikipedia.org/wiki/FASTA  

23    National Centre for Biotechnology Information. MCM5 homo sapiens [FASTA]. National Centre for Biotechnology Information [cited 2014 May 06]. Available from: http://www.ncbi.nlm.nih.gov/protein/47678565?report=fasta  

24    Wikipedia. BLAST. Wikipedia [cited 2014 May 06]. Available from: http://www.en.wikipedia.org/wiki/BLAST

25    Kelley L. 3D-PSSM (Version 2.6.0). 3D-PSSM protein fold recognition (threading) server [cited 2014 May 06]. Available from: http://www.sbg.bio.ic.ac.uk/~3dpssm/index2.html 

26    Wikipedia. Phyre/Phyre2. Wikipedia [cited 2014 May 06]. Available from: http://www.en.wikipedia.org/wiki/Phyre_/_Phyre2  

27    Kelley L et al. Phyre2 (Version 2). Protein homology analogy recognition server [cited 2014 May 06]. Available from: http://www.sbg.bio.ic.ac.uk/phyre2

28    Berman HM et al. The Protein data bank. Nucleic Acids Research. 28 (1); 2000: 235-242.

29    Research Collaboratory for Structural Bioinformatics-Protein Data Bank. RCSB Protein Data Bank- RCSB PDB (An information portal to biological macromolecular structures) [cited 2014 May 08]. Available from: http://www.rcsb.org

30    Bhusan KK. EasyModeller (Version 2.0) {Computer software} [cited 2014 May 08]. Available from: http://www.sites.google.com/site/bioinformatikz       

31    Bhusan KK, Aparoy P and Reddanna P. EasyModeller: A graphical interface to MODELLER. BMC Research Notes. 3; 2010: 226.

32    Guex N et al. DeepView-Swiss-PdbViewer (Version 4.1) {Computer software} [cited 2014 May 06]. Available from: http://www.Spdbv.vital-it.ch/   

33    NIH MBI Laboratory for Structural Genomics and Proteomics. Structural Analysis and Verification Server (Version 3). UCLA MBI-SAVES web server [cited 2014 May 10]. Available from: http://www.nihserver.mbi.ucla.edu/SAVES/  

34    Fiser A and Sali A. ModLoop: automated modeling of loops in protein structures. Bioinformatics. 19 (18); 2003: 2500-2501.

35    Fiser A. ModLoop (Version r204). ModLoop-ModBase web server [cited 2014 May 11]. Available from: https://modbase.compbio.ucsf.edu/modloop/

36    Shoichet Laboratory. ZINC {Data set} [cited 2014 May 23]. Available from: http://www.zinc.docking.org

37    The Metabolomics Innovation Centre. Drug Bank {Data set} [cited 2014 May 21]. Available from: http://www.drugbank.ca

38    Morris GM and Lim-Wilby M. Molecular docking. Methods in Molecular Biology. 443; 2008: 365-382.

39    GMMSB/LNCC. The DockThor Portal (Version 1.0) {Online docking server} [cited 2014 November]. Available from: http://www.dockthor.Incc.br

40    PerkinElmer. ChemBio3D (Ultra 13.0) {Computer software} [cited 2014 November 12]. Available from: http://www.cambridgesoft.com/Ensemble_for_chemistry/chemBio3D/

41    Schrödinger. PyMol (Version 1.7.2) {Computer software} [cited 2014 November 12]. Available from: http://www.pymol.org

42    CASPUR & University of Rome “La Sapienza. (2014). Protein Model Data Base {Data Base} [cited 2014 August 28]. Available from: http://bioinformatics.cineca.it/PMDB/

 

 

 

Received on 20.02.2015          Accepted on 10.03.2015        

© Asian Pharma Press All Right Reserved

Asian J. Pharm. Tech.  2015; Vol. 5: Issue 1, Pg 17-22

DOI: 10.5958/2231-5713.2015.00004.5